Last update 08 May 2025

CD34-positive cells(Baxter Healthcare Corporation)

Overview

Basic Info

Drug Type
Hematopoietic stem cell therapy
Synonyms-
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Cardiovascular DiseasesOther Diseases
Active Indication-
Inactive Indication
Chronic Limb-Threatening IschemiaWounds and Injuries
Originator Organization
Baxter Healthcare Corp.
Active Organization-
Inactive Organization
Baxter Healthcare Corp.
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with CD34-positive cells(Baxter Healthcare Corporation)
JPRN-jRCT2052200112
/ RecruitingPhase 2
Study of intra-carotid injection of autologous CD34-positive cells in chronic ischemic stroke between 150 and 365 days after onset
JPRN-jRCTb070190052
/ CompletedPhase 1/2IIT
Transhepatic arterial administration of G-CSF mobilized autologous peripheral blood CD34 positive cells for patients with hepatitis C virus-related liver cirrhosis
JPRN-UMIN000028965
/ CompletedPhase 1/2IIT
Transhepatic arterial administration of G-CSF mobilized autologous peripheral blood CD34 positive cells in patients with hepatitis C virus-related liver cirrhosis - Transhepatic arterial administration of G-CSF mobilized autologous peripheral blood CD34 positive cells in patients with hepatitis C virus-related decompensated liver cirrhosis
100 Clinical Results associated with CD34-positive cells(Baxter Healthcare Corporation)
Login to view more data
100 Translational Medicine associated with CD34-positive cells(Baxter Healthcare Corporation)
Login to view more data
100 Patents (Medical) associated with CD34-positive cells(Baxter Healthcare Corporation)
Login to view more data
100 Deals associated with CD34-positive cells(Baxter Healthcare Corporation)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Limb-Threatening IschemiaPhase 2
United States
Baxter Healthcare Corp.
01 Dec 2007
Wounds and InjuriesPhase 2
United States
Baxter Healthcare Corp.
01 Dec 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free